Triventures, which already has several corporate backers, has raised more than half of the capital for a $40m fund it has launched with Chaim Sheba Medical Center.

Alexandria LaunchLabs will launch in early 2021 as Stanford University looks to bolster its life sciences ecosystem and provide more flexible workspace options for its researchers.

University of Cambridge-founded autoimmune disease developer PredictImmune has expanded its IP base with first refusal rights on prognostics for systemic lupus erythematosus.

Tencent was among the investors in a series B round that will help AllinMD expand its orthopaedic training and care access platform as well as its hospitals.

The Lundbeck and Upsher-Smith-backed drug development technology provider reportedly raised the funding at half the $2bn valuation of its last round in 2018.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Fosun-backed Shanghai Henlius Biotech has priced shares at the bottom of its range to raise $410m in its initial public offering ahead of public trading next week.

Haldor Topsøe remains the largest shareholder of cancer treatment developer IGM Biosciences, whose shares have risen more than 50% since it floated yesterday.

The pharmaceutical component manufacturer has committed $50m to Colorcon Ventures, which is being managed by Touchdown Ventures.

Edgewise Therapeutics completed a $50m round co-led by Novo that will advance product candidates addressing Duchenne and Becker muscular dystrophy.